✦ LIBER ✦

Efficacy and safety of pregabalin in refractory focal epilepsy with and without comorbid anxiety disorders — Results of an open-label, parallel group, investigator-initiated, proof-of-concept study

✍ Scribed by Brandt, Christian; Schoendienst, Martin; Trentowska, Monika; Schrecke, Mario; Fueratsch, Nora; Witte-Boelt, Karin; Pohlmann-Eden, Bernd; May, Theodor W.

Book ID: 122019211
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 260 KB
Volume: 29
Category: Article
ISSN: 1525-5050
DOI: 10.1016/j.yebeh.2013.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-06.12: An open label pilot study inve

MP-06.12: An open label pilot study investigating the safety and efficacy of Botox® in 20 female patients with refractory symptoms of high urinary voiding frequency without incontinence

✍ R. Casey; C. Andreou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 138 KB

257 EFFICACY AND SAFETY OF TEVERELIX LA,

257 EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH ADVANCED PROSTATE CANCER. RESULTS FROM A PHASE II MULTI-CENTRE, OPEN-LABEL, PILOT STUDY INVESTIGATING AN INITIAL

✍ C. Maclean; F. Larsen; J. Drewe; A. Ulys; D. Kaniušas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 328 KB

EFFICACY AND SAFETY OF TEVERELIX, A NEW

EFFICACY AND SAFETY OF TEVERELIX, A NEW GONADOTROPHIN RELEASING HORMONE ANTAGONIST IN PATIENTS WITH ADVANCED PROSTATE CANCER. RESULTS FROM A PHASE 2 MULTICENTRE, OPEN-LABEL, PILOT STUDY INVESTIGATING AN INITIAL INTRAMUSCULAR LOADING DOSE REGIMEN OF TEVERELIX

✍ C. Maclean; A. Ulys; F. Jankevičius; D. Kaniušas; J. Drewe; F. Larsen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB